Skip to main content

Table 4 Treatment of patients at reporting tertiary paediatric centre

From: Childhood interstitial lung diseases in immunocompetent children in Australia and New Zealand: a decade’s experience

  N (%) All cases Diagnosis < 2 years Diagnosis ≥ 2 years
   No. reported
(Max 107)
N (%) No.reported (Max 66)a N (%) No. reported (Max 40)a
Treatment given
Steroids 62 (59.6) 104 33 (52.4) 63 29 (72.5) 40
  Response seen 28 (62.2) 45 16 (72.7) 22 12 (52.2) 23
Hydrochloroquine 36 (34.6) 104 24 (38.1) 63 12 (30.0) 40
  Response seen 12 (63.1) 19 9 (69.2) 13 3 (50.0) 6
Azithromycin 26 (25.0) 104 17 (27.0) 63 9 (22.5) 40
  Response seen 6 (50.0) 12 2 (40.0) 5 4 (57.1) 7
Azathioprine 4 (3.9) 103 1 (1.6) 62 3 (7.5) 40
  Response seen 1 (50.0) 2 1 (100.0) 1 0 (0.0) 0
Cyclophosphamide 6 (5.8) 104 0 (0.0) 63 6 (15.0) 40
  Response seen 1 (33.3) 3 - 0 1 (33.3) 3
Oxygen 23 (56.1) 41 17 (56.7) 30 6 (54.5) 11
  Response seen 4 (80.0) 5 4 (100.0) 4 0 (0.0) 1
  1. a Age at diagnosis was not documented for 1 subject